Efficacy and safety of darunavir/ritonavir in treatment-experienced HIV type-1 patients in the POWER 1, 2 and 3 trials at week 96-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of darunavir/ritonavir in treatment-experienced HIV type-1 patients in the POWER 1, 2 and 3 trials at week 96

Published:2009 Issue:6 Volume:14 Page:859-859
ISSN:2040-2058
Container-title:Antiviral Therapy
language:
Short-container-title:Antivir Ther

Author:

Arasteh Keikawus,Yeni Patrick,Pozniak Anton,Grinsztejn Beatriz,Jayaweera Dushyantha,Roberts Afsoon,Hoy Jennifer,De Meyer Sandra,Vangeneugden Tony,Tomaka Frank

Publisher

SAGE Publications

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virological outcomes of third-line antiretroviral therapy in a global context: a systematic reviews and meta-analysis;AIDS Research and Therapy;2024-06-25

2. No effects of nirmatrelvir/ritonavir on darunavir plasma trough concentrations: a case report;European Journal of Hospital Pharmacy;2024-01-10

3. Incidence of cardiometabolic outcomes among people living with HIV‐1 initiated on integrase strand transfer inhibitor versus non‐integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States;Journal of the International AIDS Society;2023-06

4. Real-world weight changes in people with HIV-1 at risk of weight gain (female, Black or Hispanic) switching from integrase strand transfer inhibitors;Journal of Comparative Effectiveness Research;2023-01

5. Evaluating fostemsavir as a therapeutic option for patients with HIV;Expert Opinion on Pharmacotherapy;2021-06-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP